Impact of COVID-19 on the time to counseling and treatment of prostate cancer

Purpose This study investigates how the COVID-19 pandemic (CP) impacted the timeline between initial diagnosis (ID) of prostate carcinoma and subsequent therapy consultation (TC) or radical prostatectomy (RP) due to the implementation of a “minimal contact concept,” which postponed clinical examinat...

Full description

Saved in:
Bibliographic Details
Main Authors: Dejan K. Filipas, Randi M. Pose, Phillip Marks, Pierre Tennstedt, Burkhard Beyer, Derya Tilki, Hendrik Isbarn, Tobias Maurer, Tim A. Ludwig, Hans Heinzer, Thomas Steuber
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:The Aging Male
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13685538.2024.2347465
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850059234557820928
author Dejan K. Filipas
Randi M. Pose
Phillip Marks
Pierre Tennstedt
Burkhard Beyer
Derya Tilki
Hendrik Isbarn
Tobias Maurer
Tim A. Ludwig
Hans Heinzer
Thomas Steuber
author_facet Dejan K. Filipas
Randi M. Pose
Phillip Marks
Pierre Tennstedt
Burkhard Beyer
Derya Tilki
Hendrik Isbarn
Tobias Maurer
Tim A. Ludwig
Hans Heinzer
Thomas Steuber
author_sort Dejan K. Filipas
collection DOAJ
description Purpose This study investigates how the COVID-19 pandemic (CP) impacted the timeline between initial diagnosis (ID) of prostate carcinoma and subsequent therapy consultation (TC) or radical prostatectomy (RP) due to the implementation of a “minimal contact concept,” which postponed clinical examinations until the day of admission.Methods We analyzed patient data from a tertiary care center from 2018 to September 2021. The focus was on comparing the time intervals from ID to TC and from ID to RP before and during the CP.Results Of 12,255 patients, 6,073 (61.6%) were treated before and 3,791 (38.4%) during the CP. The median time from ID to TC reduced from 37 days (IQR: 21 – 58d) pre-CP to 32 days (IQR: 20 – 50d) during CP (p < 0.001). Similarly, the time from ID to RP decreased from 98 days (IQR: 70 – 141d) to 75 days (IQR: 55 – 108d; p < 0.001) during the CP. There was a significant decrease in low-risk tumor cases at ID (18.9% vs. 21.4%; p = 0.003) and post-RP (4% vs. 6.7%; p < 0.001) during the CP.Conclusion Our findings suggest that the COVID-19 pandemic facilitated more timely treatment of prostate cancer, suggesting potential benefits for both low-risk and aggressive tumor management through expedited clinical procedures.
format Article
id doaj-art-9053788cd0884f2fa0305e136a4688ca
institution DOAJ
issn 1368-5538
1473-0790
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series The Aging Male
spelling doaj-art-9053788cd0884f2fa0305e136a4688ca2025-08-20T02:50:56ZengTaylor & Francis GroupThe Aging Male1368-55381473-07902024-12-0127110.1080/13685538.2024.2347465Impact of COVID-19 on the time to counseling and treatment of prostate cancerDejan K. Filipas0Randi M. Pose1Phillip Marks2Pierre Tennstedt3Burkhard Beyer4Derya Tilki5Hendrik Isbarn6Tobias Maurer7Tim A. Ludwig8Hans Heinzer9Thomas Steuber10Martini-Klinik Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyMartini-Klinik Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyMartini-Klinik Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyMartini-Klinik Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyMartini-Klinik Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyMartini-Klinik Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyMartini-Klinik Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyMartini-Klinik Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyMartini-Klinik Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyMartini-Klinik Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyMartini-Klinik Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyPurpose This study investigates how the COVID-19 pandemic (CP) impacted the timeline between initial diagnosis (ID) of prostate carcinoma and subsequent therapy consultation (TC) or radical prostatectomy (RP) due to the implementation of a “minimal contact concept,” which postponed clinical examinations until the day of admission.Methods We analyzed patient data from a tertiary care center from 2018 to September 2021. The focus was on comparing the time intervals from ID to TC and from ID to RP before and during the CP.Results Of 12,255 patients, 6,073 (61.6%) were treated before and 3,791 (38.4%) during the CP. The median time from ID to TC reduced from 37 days (IQR: 21 – 58d) pre-CP to 32 days (IQR: 20 – 50d) during CP (p < 0.001). Similarly, the time from ID to RP decreased from 98 days (IQR: 70 – 141d) to 75 days (IQR: 55 – 108d; p < 0.001) during the CP. There was a significant decrease in low-risk tumor cases at ID (18.9% vs. 21.4%; p = 0.003) and post-RP (4% vs. 6.7%; p < 0.001) during the CP.Conclusion Our findings suggest that the COVID-19 pandemic facilitated more timely treatment of prostate cancer, suggesting potential benefits for both low-risk and aggressive tumor management through expedited clinical procedures.https://www.tandfonline.com/doi/10.1080/13685538.2024.2347465prostatic neoplasmstime-to-treatmentCOVID-19counselingradical prostatectomypatient care management
spellingShingle Dejan K. Filipas
Randi M. Pose
Phillip Marks
Pierre Tennstedt
Burkhard Beyer
Derya Tilki
Hendrik Isbarn
Tobias Maurer
Tim A. Ludwig
Hans Heinzer
Thomas Steuber
Impact of COVID-19 on the time to counseling and treatment of prostate cancer
The Aging Male
prostatic neoplasms
time-to-treatment
COVID-19
counseling
radical prostatectomy
patient care management
title Impact of COVID-19 on the time to counseling and treatment of prostate cancer
title_full Impact of COVID-19 on the time to counseling and treatment of prostate cancer
title_fullStr Impact of COVID-19 on the time to counseling and treatment of prostate cancer
title_full_unstemmed Impact of COVID-19 on the time to counseling and treatment of prostate cancer
title_short Impact of COVID-19 on the time to counseling and treatment of prostate cancer
title_sort impact of covid 19 on the time to counseling and treatment of prostate cancer
topic prostatic neoplasms
time-to-treatment
COVID-19
counseling
radical prostatectomy
patient care management
url https://www.tandfonline.com/doi/10.1080/13685538.2024.2347465
work_keys_str_mv AT dejankfilipas impactofcovid19onthetimetocounselingandtreatmentofprostatecancer
AT randimpose impactofcovid19onthetimetocounselingandtreatmentofprostatecancer
AT phillipmarks impactofcovid19onthetimetocounselingandtreatmentofprostatecancer
AT pierretennstedt impactofcovid19onthetimetocounselingandtreatmentofprostatecancer
AT burkhardbeyer impactofcovid19onthetimetocounselingandtreatmentofprostatecancer
AT deryatilki impactofcovid19onthetimetocounselingandtreatmentofprostatecancer
AT hendrikisbarn impactofcovid19onthetimetocounselingandtreatmentofprostatecancer
AT tobiasmaurer impactofcovid19onthetimetocounselingandtreatmentofprostatecancer
AT timaludwig impactofcovid19onthetimetocounselingandtreatmentofprostatecancer
AT hansheinzer impactofcovid19onthetimetocounselingandtreatmentofprostatecancer
AT thomassteuber impactofcovid19onthetimetocounselingandtreatmentofprostatecancer